Litigation Details for Astellas Pharma Inc. v. Cipla Limited (D. Del. 2018)
✉ Email this page to a colleague
Astellas Pharma Inc. v. Cipla Limited (D. Del. 2018)
| Docket | ⤷ Sign Up | Date Filed | 2018-06-05 |
| Court | District Court, D. Delaware | Date Terminated | 2018-08-23 |
| Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
| Jury Demand | None | Referred To | |
| Patents | 6,017,927 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Astellas Pharma Inc. v. Cipla Limited
The small molecule drug covered by the patent cited in this case is ⤷ Sign Up .
Details for Astellas Pharma Inc. v. Cipla Limited (D. Del. 2018)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2018-06-05 | 1 | Complaint | an action for patent infringement of United States Patent No. 6,017,927 (“the ’927 patent”), arising under…BACKGROUND A. The ’927 Patent 15. The United States Patent and Trademark Office duly and…correct copy of the ’927 patent is attached as Exhibit A. 16. The ’927 patent claims, inter alia…927 patent. 22. AICL and APEL are exclusive licensees of rights under the ’927 patent. …x27;927 Patent. 35. On information and belief, Cipla was aware of the ‘927 patent and its | External link to document |
| 2018-08-23 | 14 | Order | relating to United States Patent No. 6,017,927 ("the ' 927 patent"); WHEREAS…IV certification with respect to the '927 patent to a Paragraph III certification pursuant to which…which it agrees that the '927 patent, plus any other exclusivity, will expire before the requested…earlier than the expiration date of the '927 patent, including any extensions and/or additional periods…III certification with respect to the '927 patent, the parties have resolved this action; | External link to document |
| 2018-08-27 | 15 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,017,927. (Attachments: # 1 …2018 23 August 2018 1:18-cv-00844 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
